We're sorry. An error has occurred
Please cancel or retry.
The China Cure
Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
- Format:
-
15 October 2026
This is a book about health under pressure, and about what becomes possible when a country of immense scale is forced to innovate in one of the most difficult and intimate domains of public life. Some of what emerges is impressive, some of it is troubling and much of it remains unresolved. China has embraced innovation and technology in health care to tackle its own huge healthcare burdens. The strain of chronic ill health is both a challenge to the existing system and an opportunity to innovate in biotechnology and digital health. China’s ability to operate at tremendous scale and pace has enabled it to become a global health leader in a matter of decades. Dr Ruby Wang offers an insider’s perspective of where it offers lessons for both developed and developing countries, and how its rise is already impacting the practice and delivery of medicine worldwide.
MEDICAL / Health Care Delivery, Health systems and services, POLITICAL SCIENCE / Public Policy / Economic Policy, BUSINESS & ECONOMICS / Economics / General, HEALTH & FITNESS / Health Care Issues, POLITICAL SCIENCE / Political Economy, SCIENCE / Biotechnology, BUSINESS & ECONOMICS / Industries / Manufacturing, Health economics, Biotechnology, Chemical, biotechnology and pharmaceutical industries
Dr Ruby Wang is a clinician, strategist and writer working across health, technology, policy and global governance. Born in China and raised in the UK, she brings together clinical, policy and personal experience of health systems across borders.
She trained in medicine at Cambridge, Oxford and University College London, including a master’s in neuroscience and psychology, and completed another master’s in global affairs at Tsinghua University as a Schwarzman Scholar. She has worked on healthtech and policy alongside clinical practice in the UK’s National Health Service, and during the COVID-19 pandemic, she served as Head of Health for the UK Government in China and as Health Advisor to the United Nations in Beijing. She is founder of LINTRIS Health consultancy, Digital Health Council at the Royal Society of Medicine, Fellow on Global Health at the Asia Society and editor at ChinaHealthPulse, a newsletter and podcast that diagnoses the global impact of China’s health.
Foreword by Kerry Brown
Introduction
1. Culture and Crisis: Innovation Under Pressure
2. Biotech Powerhouse
3. Digital-First Health
4. The Human Side: Doctors and Patients
5. The Institutional Engines of Change
6. Health Innovation Across Borders: Global Influence
7. The Global Stakes